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Global glomerulosclerosis can be divided in the vascular
(obsolescent) type and the glomerulopathic (solidified) type.
In biopsies from children with recurrent nephrotic syndrome
owing to minimal change nephropathy (MCN), we noticed
small, globally sclerosed glomeruli that appeared to be
distinct from global glomerulosclerosis. These small sclerosed
glomeruli are best described as involuted glomeruli. We have
characterized these involuted glomeruli in detail. We studied
biopsies of 18 children (11 male, 7 female) with frequently
relapsing MCN and evaluated possible explanatory variables.
The involuted glomeruli can be differentiated from the other
types of global glomerulosclerosis. Most notable is the
presence of vital podocytes and parietal epithelial cells,
which have retained their staining characteristics, in between
the matrix, and the absence of periglomerular and tubulo-
interstitial fibrosis. We observed involuted glomeruli in
12 out of 18 biopsies; the median percentage of involuted
glomeruli was 6% (range 0–33%). The percentage of
involuted glomeruli correlated with age at renal biopsy and
the interval between onset of disease and time of renal
biopsy, but not with gender, age at onset of disease, or
prednisone dose. Multivariate analysis revealed that the
interval between onset of disease and time of renal biopsy
was the only independent predictor. In conclusion,
glomerular involution is a special form of global
glomerulosclerosis. The absence of periglomerular and
tubulo-interstitial fibrosis suggests a different pathogenesis.
Glomerular involution is a slow process. The clinical data
suggest that involution is related to the duration of the
disease process.
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With advancing age the number of globally sclerosed glomeruli
in the human kidney increases. This is a more or less
physiological phenomenon that is related to arteriosclerosis.
More than 10% globally sclerosed glomeruli is considered as
pathological for persons over the age of 40 years.1,2 Two types
of global glomerulosclerosis can be distinguished: the vascular
type (also referred to as obsolescent type) and the glomerulo-
pathic type (also referred to as solidified type).3 Vascular
glomerulosclerosis is characterized by a retracted glomerular
tuft without tuft adhesions, surrounded by a hypocellular
homogeneous collagenous matrix in the former Bowman’s
space (only recognizable in a silver or periodic acid-Schiff
stain). Glomerulopathic sclerosis is characterized by a solidified
non-retracted glomerular tuft with often recognizable tuft
adhesions and without the homogeneous collagenous matrix
in Bowman’s space. The former is mostly associated with
decreased perfusion resulting from arterial intimal fibrosis in
aging or hypertension, whereas the latter form is the result of
ongoing damage in glomerular diseases. It has been suggested
that global sclerosis may also occur without renal disease as
part of a normal damage and repair process. In fact, globally
sclerosed glomeruli have been found in children below the age
of 2 years.4 Notably, global glomerulosclerosis is always
accompanied by tubulo-interstitial fibrosis. In recent years,
Kriz et al.5 have proposed the concept of misdirected filtration
as a mechanism by which glomerulosclerosis leads to
periglomerular and tubulo-interstitial fibrosis.
We recently noticed globally sclerosed glomeruli that
appeared to be distinct from either vascular or glomerulo-
pathic glomerulosclerosis in biopsies from children with
recurrent nephrotic syndrome. These sclerosed glomeruli are
characterized by a marked reduction in size and apparent lack
of accompanying tubular atrophy and interstitial fibrosis.
Small globally sclerosed glomeruli in the setting of congenital
or childhood nephrotic syndrome in children o1 year have
been previously noticed by others and were referred to as
‘microglomeruli’ in the old literature.6 However, it has not
been investigated whether these glomeruli truly represent a
distinct type of sclerosis. It was reported that their presence
does not predict prognosis in the setting of congenital
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nephrotic syndrome, but other than that their potential
meaning has not been addressed. In the present study, we
have characterized these glomeruli in detail by light
microscopy, immunostainings, and electron microscopy,
and made a comparison with the classical vascular type of
glomerulosclerosis and the glomerulopathic type of glomer-
ulosclerosis in the setting of focal and segmental glomerulo-
sclerosis (FSGS). In addition, we have studied biopsies of
children with a frequently relapsing minimal change nephro-
tic syndrome (MCNS) for the presence of involuted glomeruli
and evaluated possible explanatory variables.
Our findings indicate that the small globally sclerosed
glomeruli in the setting of childhood nephrotic syndrome
represent a unique type of glomerular injury, best described
by the term glomerular involution. We hypothesize that this
is a special form of glomerulosclerosis with a different
pathogenesis.
RESULTS
We initially noticed the presence of small globally sclerosed
glomeruli without accompanying interstitial changes in bio-
psies of children with recurrent nephrotic syndrome. Of note,
these small sclerosed glomeruli were not seen in five biopsies
from children with non-nephrotic kidney disease. We have
characterized these small sclerosed glomeruli, which will be
referred to as glomerular involution, in detail and made
comparison with globally sclerosed glomeruli of the glomer-
ulopathic type and vascular type.
Morphology
As compared to the classical forms of global sclerosis, in
involution there is a marked reduction in diameter
(approximately a quarter of the diameter of an open
glomerulus). In the silver stainings with low power
magnification, involuted glomeruli appear as small black
nodules without apparent accompanying interstitial changes
(Figure 1a). For comparison see Figure 2a and b for globally
sclerosed glomeruli of the glomerulopathic and vascular type,
respectively. In fact, if present in low numbers involuted
glomeruli can easily be overlooked. They are mostly evenly
distributed throughout the cortex, although sometimes there
is a predominant subcapsular localization. On closer
examination, involuted glomeruli are made up of strong
staining (non-hyalinized) extracellular matrix, comparable to
the matrix observed in glomerulopathic sclerosis. This
matrix, likely composed of remnants of the glomerular
basement membrane (GBM) and Bowman’s capsule, has the
appearance of an interconnecting network in continuity with
the former glomerular tuft and Bowman’s capsule (Figure 1b
and c). In addition, a small number of vital appearing cells
are usually seen unlike in vascular sclerosis, where the
contracted tuft does usually not contain any cells (see below).
Remarkably, there is no splitting or duplication of Bowman’s
capsule, as is usually observed in glomerulopathic sclerosis.
Also, there is no stromal reaction or hypercellularity of the
surrounding interstitium, which is usually markedly present
in glomerulopathic sclerosis and to a lesser extent also in
vascular sclerosis. A few atrophic tubular structures, probably
remnants of the tubular apparatus, can often be identified in
proximity of involuted glomeruli (Figure 1b, arrow). Electron
microscopy confirmed the presence of vital appearing cells
that cover either the GBM or Bowman’s capsule in the
involuted glomeruli, whereas these are absent in the other
types of global glomerulosclerosis (data not shown).
a
b c
Figure 1 | (a) Histology, silver methenamine staining: with
low magnification involuted glomeruli appear as small black
nodules. They are distributed throughout the cortex, without
the presence of accompanying interstitial changes. (b and c) In detail,
the extracellular matrix strongly stains a network composed of
remnants of the GBM and Bowman’s capsule. Embedded in
the matrix, there are a certain number of vital appearing cells.
(b) Sporadically atrophic tubules can be seen close to involuted
glomeruli (arrow) (original magnification a:  150; b, c:  750).
a b
Figure 2 | (a) Types of global glomerulosclerosis: an example of
glomerulopathic glomerulosclerosis also referred to as solidified
type as shown in panel a. Glomerulopathic glomerulosclerosis is
characterized by a solidified non-retracted glomerular tuft with often
recognizable tuft adhesions, splitting of Bowman’s capsule, and
prominent periglomerular fibrosis. (b) An example of vascular
glomerulosclerosis is shown in panel b. This type is characterized
by the retracted glomerular tuft, surrounded by a hypocellular
homogeneous collagenous matrix in the former Bowman’s space,
without tuft adhesions. There usually is moderate periglomerular
fibrosis (original magnification a, b:  500).
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Identifiable interrupted stretches of GBM are seen and both
the GBM and Bowman’s capsule are in part thickened
(Figure 3, arrows).
Immunohistochemistry
We characterized the three types of global glomerulosclerosis,
glomerular involution (Figures 4–6 (a–d)), glomerulopathic
glomerulosclerosis (Figures 4–6 (e–h)), and vascular glomer-
ulosclerosis (Figures 4–6 (i–l)), by immunostainings for syna-
ptopodin and CD10 (podocytes), CK8 and PAX2 (parietal
cells), CD68 (macrophages), a-smooth muscle actin, (myofi-
broblasts, mesangial cells), CD34 (endothelium), vimentin
and extracellular matrix components collagen I, III, and IV,
and the a1 and a5 chain of collagen IV (Table 1).
Remarkably, in involuted glomeruli some of the remaining
cells stained for podocyte markers synaptopodin (Figure 4b)
and CD10 (Figure 4c) and for parietal epithelial cell (PEC)
marker paired box gene 2 (transcription factor) (PAX-2) and
(Figure 4d), whereas cells positive for these markers were
neither seen in glomerulopathic sclerosis nor in vascular
sclerosis (parallel panels).
The extracellular matrix characteristics of the different
types are depicted in Figure 5. Collagen III was negative in all
types of sclerosis (data not shown). The hyalinized extra-
cellular matrix filling Bowman’s space in vascular sclerosis
was strongly positive for collagen I (Figure 5j), whereas
collagen I was not detected in involuted glomeruli (Figure
5b) or glomerulopathic sclerosis (Figure 5f). Collagen IV
stains all of the matrix in involution and glomerulopathic
sclerosis and only the contracted glomerular tuft in vascular
sclerosis (Figure 5a, e, and i). There was staining for both the
a-1 and a-5 chain of collagen IV in involuted glomeruli
(Figure 5c and d) and glomerulopathic sclerosis (Figure 5g
and h), whereas in vascular sclerosis the Bowman’s capsule
was stained for the a-1 chain (Figure 5k) and the contracted
tuft stained only for a-5 (Figure 5l).
CK8 positivity, a marker for activated PECs, was not seen
(Figure 6a). CK8 is not normally expressed in glomeruli, but
can become expressed on parietal cells in FSGS.7 We observed
residual staining in involuted glomeruli for smooth muscle
actin (Figure 6b) and CD34 (Figure 6c), possibly representing
residual endothelial cells and mesangial cells. Intriguingly,
smooth muscle actin staining was almost absent in the
periglomerular region of the involuted glomeruli (Figure 6b),
this in contrast to the staining, which was very pronounced
in glomerulopathic sclerosis and in vascular sclerosis (Figure
6f and j). Staining of capillary remnants for CD34 was
observed in vascular sclerosis and involuted glomeruli, but
not in glomerulopathic sclerosis (Figure 6g and k).
The remarkable absence of interstitial changes accompa-
nying glomerular involution was further highlighted by
vimentin (Figure 6d, h, and l), staining that showed promi-
nent periglomerular expression in glomerulopathic sclerosis,
but not in involuted glomeruli.
All typical glomerular characteristics of the three forms of
glomerulosclerosis are listed in Table 2.
Patients
We have studied the biopsies of 18 children with a steroid-
dependent or frequently relapsing MCNS.
Clinical characteristics of the patients are given in Table 3.
There were 11 boys and seven girls. Median age at disease
onset was 2.8 years (1.6–10.6 years) and at biopsy 5.2 years
(2.3–10.9 years). Most patients expressed a frequently
relapsing course of the nephrotic syndrome. All patients
had received prednisone. Other immunosuppressive agents
had not been used before the renal biopsy. All patients were
initially treated according to the guidelines of the ISKDC.
Some patients with steroid-dependent nephrotic syndrome
were treated with low-dose prednisone for prolonged time
periods with titration of the prednisone dose against
proteinuria assessed by urinary dipstick. The biopsies
contained 19 (5–35) glomeruli. Many biopsies contained
small, globally sclerosed glomeruli, with the characteristics of
involuted glomeruli. The median percentage of involuted
glomeruli was 6% (range 0–33%). Biopsies of six patients did
not show involuted glomeruli. When comparing patients
without and with involuted glomeruli, we observed a
significant difference in the age at renal biopsy (without
involution: 3.971.1 year, with involution 6.572.6 years;
Po0.05) and the interval between onset of disease and the
renal biopsy (0.4470.43 years vs 3.873.3 years; Po0.01).
There were no significant differences in gender distribution,
maximal proteinuria at onset, serum albumin, and number
of recurrences or selectivity index. There was a significant
correlation between the percentage of involuted glomeruli
and the interval between onset of disease and renal biopsy
(Figure 7, Spearman R¼ 0.64; Po0.01), and a trend between
Figure 3 | Transmission electron microscopy of an involuted
glomerulus: the observations by light microscopy (Figure 1)
are confirmed at high magnification by electron microscopy.
Involuted glomeruli show an interconnecting network of GBM and
Bowman’s capsule. Vital appearing cells are present. Cells that cover
the GBM show foot process effacement and sometimes a single
cell forms bridges between Bowman’s capsule and the GBM (arrows).
The former GBM and Bowman’s capsule are thickened by irregular
duplication and matrix deposition (original magnification  7000).
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age at biopsy and percentage involution (r¼ 0.41; P¼ 0.09).
By logistic regression analysis, the interval between disease
onset and the renal biopsy was the only independent
significant predictor. We also have evaluated the relation
between glomerular involution and outcome. Percentage
involution was not related to outcome. All but two patients
were treated with cyclophosphamide. Recurrences of the
nephrotic syndrome occurred in three of six patients without
involuted glomeruli and in four of eight patients with 45%
involuted glomeruli. At the end of follow-up, all patients but
one were in remission.
DISCUSSION
Our findings justify the conclusion that glomerular involu-
tion is a type of glomerulosclerosis distinct from glomerulo-
pathic and vascular glomerulosclerosis. The most evident
distinguishing features are reduced size, remaining vital
cells that stain for podocyte and parietal markers, and a
remarkable absence of periglomerular fibrosis or interstitial
damage.
These involuted glomeruli are regularly found in patients
with frequently relapsing or steroid-dependent MCNS. In
our series, these glomeruli were observed in the majority
(two-thirds) of the renal biopsies and were not found in the
controls.
It is likely that glomerular involution has been noted by
other investigators although a clear description is lacking.
Emery and Macdonald4 described glomerular involution and
scarring in children, a process unlikely to be the result of
vascular injury. They observed these scarred glomeruli in
children, occurring predominantly in children aged o2
years, with preferential localization in the subcapsular region
and in approximity to the arcuate vessels. In the paper,
glomerular involution is described as the presence of small
solid masses of connective tissue-like material lacking
epithelial cells. Similar findings have been reported by
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Figure 4 | Phenotype of glomerular cells: cells in (a–d) glomerular involution, (e–h) glomerulopathic glomerulosclerosis, and
(i–l) vascular glomerulosclerosis. Light microscopy periodic acid-Schiff (PAS staining) is shown in panel a, e, and i. Podocyte markers
(b) synaptopodin, (c) CD10, and (d) the PECs marker (PAX-2) are still expressed in involuted glomeruli and not in the other two
types of glomerulosclerosis (original magnification a–d:  400; e–l:  250).
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Herxheimer,8 who noted hyalinized glomeruli in childreno1
year. Both reports do not mention the tubulo-interstitium.
However, based on the description (lacking epithelial cells)
and the predominant occurrence at very young age, it is
unlikely that these glomeruli may match our findings. Sibley
et al.6 described the occurrence of microglomeruli in children
with a congenital nephrotic syndrome. The microglomeruli
averaged 20–40 mm in diameter and contained capillaries. The
description of the glomeruli fits our findings, although no
mention is made of tubulo-interstitial injury.6
Many studies have addressed global glomerulosclerosis.9 It
was shown that the number of obsolescent glomeruli
increased with age, and correlated with interstitial fibrosis
and arteriolar intimal hyperplasia.9 Glomerular involution
appears to be very different from vascular glomerulosclerosis
as there is no contraction of the glomerular tuft and no
deposition of collagen I but rather production of collagen IV.
Moreover, we did not detect any vascular changes in the renal
tissue of patients with involuted glomeruli. The random
distribution of the involuted glomeruli also argues against
a vascular cause. Thus, whereas vascular sclerosis is thought
to occur secondary to hypoperfusion, such a pathogenesis is
unlikely in glomerular involution.
It is intruiging that glomerular involution occurs in the
setting of MCN in patients with relapses (recurrent nephrotic
syndrome) and therefore like FSGS is seen in the context
of proteinuria. Therefore, one could ask if glomerular
involution and glomerulopathic sclerosis in FSGS are related
processes. From a histological point of view, the most
apparent similarity is that in both types of glomerulosclerosis
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Figure 5 | Extracellular matrix characteristics in (a–d) glomerular involution, (e–h) glomerulopathic glomerulosclerosis, and
(i–l) vascular glomerulosclerosis. Collagen IV stains all of the matrix in (a) glomerular involution, (e) glomerulopathic sclerosis, and
only the contracted glomerular tuft in (i) vascular glomerulosclerosis. Collagen I only stains the hyalinized extracellular matrix filling
Bowman’s space in (j) vascular glomerulosclerosis. (c and d) The interconnecting network in involuted glomeruli stains for both the a-1 and
a-5 chain of collagen IV. (g and h) Staining of the a-1 and a-5 chain of collagen IV was also seen in glomerulopathic glomerulosclerosis,
whereas in (k) vascular glomerulosclerosis Bowman’s capsule stains for the a-1 chain and (l) the contracted tuft stains for the a-5 chain of
collagen IV (original magnification a–d:  400; e–l:  250).
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solidification is the result of matrix deposition by residual
glomerular cells, which results in an ‘inflated’ glomerulus and
tuft adhesions. In the last years, the pathogenesis of
glomerulosclerosis in FSGS has become much clearer.10–13 It
is generally accepted that in FSGS the podocyte is the cell that
is initially injured, causing proteinuria. Studies in animal
models have elucidated the following sequence of events,
which contribute to the characteristic lesions of FSGS:
podocytes loose their differentiation markers and disappear,
there is activation and proliferation of PECs or dediffer-
entiated podocytes, and deposition of matrix with the
formation of the characteristic scar. The adhesions between
the glomerular tuft and Bowman’s capsule are responsible for
misdirected filtration, moving ultrafiltrate in the periglomer-
ular space, stimulating myofibroblast proliferation. This
periglomerular ultrafiltrate typically spreads to the peritub-
ular space. We have confirmed these abnormalities in human
FSGS, and proposed that injury to PECs is important in this
process.7
In glomerular involution, there is also deposition of
extracellular matrix by cells of glomerular origin, causing
consolidation and tuft adhesions. However, in involuted
glomeruli there is no evidence of cell proliferation, podocyte
markers remain present, there is no activation of PECs, and
no periglomerular fibrosis or interstitial fibrosis. Based on
these findings, we hypothesize that misdirected filtration does
not occur in the process of glomerular involution. Appar-
ently, glomerular involution occurs in the setting of podocyte
injury with proteinuria, resulting in production of matrix by
glomerular epithelial cells, but insufficient to cause PEC
damage and allowing misdirected filtration. Alternatively, it
cannot be excluded that factors produced by activated PECs
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Figure 6 | Staining characteristics of the periglomerular region in (a–d) glomerular involution, (e–h) glomerulopathic glomerulo-
sclerosis, and (i–l) vascular glomerulosclerosis. (a, e, and i) CK8 is an activation marker of PECs in FSGS and is not expressed within the
different types of sclerosed glomeruli but only stains tubular epithelium. In glomerulopathic and vascular sclerosis, the periglomerular fibrosis is
highlighted by staining for vimentin and SMA (smooth muscle actin) (myofibroblasts) and CD34 (periglomerular capillaries). (b and d) Note the
absence of interstitial reaction in glomerular involution (original magnification a–d:  400; e–l:  250).
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and/or podocytes directly induce periglomerular fibrosis in
FSGS and that during glomerular involution such stimulating
factors are not produced.
We have noticed these involuted glomeruli in children
with minimal change disease, who were biopsied because of a
relapsing cause of the disease. Therefore, we looked for
clinical variables that could be associated with glomerular
involution. We observed a significant relation between the
percentage of glomerular involution and the interval between
onset of disease and time of renal biopsy. Thus, involuted
glomeruli are predominately observed in children who are
biopsied several years after onset of the disease. We did not
find a relation with number of recurrences, proteinuria
selectivity index, maximal proteinuria at onset, or serum
albumin. Obviously, our study has the limitations of a
retrospective study. In particular, it was impossible to obtain
accurate and meaningful data on time-averaged proteinuria.
Especially, patients with a more protracted course were
advised to check their urine by dipstick and adjust the dose
and duration of prednisone therapy accordingly. Detailed
information obviously cannot be retrieved from the patient
records. Therefore, we cannot draw conclusions on possible
mechanisms of glomerular involution. Glomerular involution
may be the consequence of the initial glomerular injury,
slowly developing afterward. Alternatively, it is quite possible
that glomerular involution is the consequence of ongoing
subtle injury, reflected by continuous recurrences of protein-
uria, suggesting a progressive pathology, which increases in
time. The prolonged use of prednisone may offer a third
explanation. In an animal model of MCN, the so-called
puromycin aminonucleoside model, chronic administration
of methylprednisolone caused glomerulosclerosis,14 an effect
attributed to hyperfiltration. Chronic steroid treatment has
also been implicated as cause of glomerulosclerosis. Pro-
spective studies are needed to determine the best explanation.
Table 1 | Antibodies used for the detection of glomerular antigens
Antigen Primary antibody Dilution Supplier/reference
Podocyte components
Synaptopodin Mouse anti-synaptopodin 1 Progen, Heidelberg, Germany
CD10 Mouse anti-human CD10 50 Monosan, Caltag lab., Burlinggame
PEC components
PAX-2 Rabbit anti-human PAX-2 50 Zymed laboratories Inc., San Francisco, CA, USA
Cytokeratin Mouse anti-human CAM 5.2 (CK8) 50 BD Biosciences, San Diego, CA, USA
Miscellaneous
a-SMA Mouse anti-human SMA 15 000 Sigma, St Louis, MO, USA
Endothelium Mouse anti-human CD34 40 Monosan, Caltag lab., Burlinggame
Vimentin Mouse anti-human vimentin 800 Biogenex, Ramon, CA, USA
Collagen IV Mouse anti-human collagen IV 1250 Sigma, St Louis, MO, USA
Collagen IV a-1 Mouse anti-a-1 collagen 40 Wieslab, Lund, Sweden
Collagen IV a-5 Mouse anti-a-5 collagen 10 Wieslab, Lund, Sweden
Collagen I Rabbit anti-human collagen I 40 Monosan, Caltag lab., Burlinggame
Collagen III Mouse anti-human collagen III 10 Monosan, Caltag lab., Burlinggame
Macrophage Mouse anti-human CD68 2000 Dako, Glostrup, Denmark
CAM, anti-cytokeratin (cam 5.2); PAX-2, paired box gene 2 (transcription factor); PEC, parietal epithelial cell; SMA, smooth muscle actin.
Table 2 | Typical characteristics of the different types
Glomerular
components Normal Involution
Glomerulo-
pathic
sclerosis
Vascular
sclerosis
Podocyte components
Synaptopodin + + = =
CD10 + + = =
PEC components
PAX-2 + + = =
Cytokeratin 8 = = = =
Proliferation
KI 67 = = = =
Miscellaneous
Macrophage (CD68) = = = =
a-SMA
Intra glomerular + + + +
Peri glomerular = = + +
Endothelium (CD34) + + = +
Collagen IV + + + =(BS)/+T
Collagen I = = = +(BS)
Collagen III = = = =
Glomerular
volume
Normal
150–250mm
Very small
30–40mm
Normal
150–250mm
Normal
150–250mm
BS, Bowman’s space; SMA, smooth muscle actin; T, glomerular tuft.
=, stands for negative.
Table 3 | Clinical characteristics of the patients
Patients (N) 18
Sex (M/F) 11/7
Age at onset (years) 2.8 (1.6–10.6)
Age at biopsy (years) 5.2 (2.3–10.9)
Interval onset–biopsy (years) 1.5 (0.2–6.7)
Number of relapses 2 (1–16)
Number of glomeruli 19 (5–35)
Involuted glomeruli (%) 6 (0–33)
F, female; M, male.
Values are given as medians (range).
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Obviously, involuted glomeruli have lost their function. The
observation that up to 30% of glomeruli are involuted in
biopsies of children with MCNS thus suggests that MCN is
not so benign as suggested. Although renal function
abnormalities were not detected in these children by standard
creatinine assays, loss of functional nephrons may cause
problems in the future. Therefore, more information is
needed on the pathogenesis of this process, to further clarify
the relation between proteinuria, treatment, and the devel-
opment of glomerular involution.
In conclusion, we describe a distinct type of global
sclerosis that is observed in the setting of children with
recurrences of MCNS. This type of glomerulosclerosis with-
out periglomerular and interstitial fibrosis is best described as
glomerular involution, a special form of glomerulosclerosis
with a different pathogenesis.
MATERIALS AND METHODS
Patients
Small glomeruli are often recognized in renal biopsies of children
with minimal change disease. We have evaluated renal biopsies of
children with a frequently relapsing nephrotic syndrome. These
children were biopsied in the process of preparation for cyclopho-
sphamide therapy. We only included biopsies classified as MCN by
appropriate histological techniques (light microscopy, immuno-
fluorescence, and electronmicroscopy).
We have counted the number of small globally sclerosed
glomeruli in the biopsies of 18 children (age 3–9 years) with
MCN. All patients had presented with a nephrotic syndrome and
were biopsied because of a frequent relapsing or steroid-dependent
course. The clinical data of the patients were studied with particular
emphasis on age of onset of disease, number of relapses, type and
duration of immunosuppressive treatment, and relapse-free interval.
For comparison, we studied five biopsies from children without
proteinuria. Their primary diagnosis was hyperoxaluria and thin
basement membrane nephropathy. To investigate the involuted
glomeruli in more detail, we used biopsies of three patients with
minimal change disease. For comparison, we used nephrectomy
specimens with evidence of the other types of global glomerulo-
sclerosis. Vascular sclerosis was investigated in the normal cortex of a
male, 74-year-old patient, nephrectomized because of a renal clear
cell carcinoma. We studied the solidified type of global sclerosis in a
nephrectomized kidney from a patient with end-stage FSGS.
Light microscopy, Immunohistochemistry, and electron
microscopy
Light microscopy. For light microscopy, kidney fragments were
fixed in Bouin’s solution or formaldehyde, dehydrated, and
embedded in paraplast (Amstelstad, Amsterdam, The Netherlands).
Two-micrometer sections were stained with periodic acid-Schiff,
and with silver methenamine. Involuted glomeruli were identified by
high-power magnification. Glomeruli were scored and counted by
one of us (HD), who was unaware of the clinical data of the patients.
Immunohistochemistry. Immunohistochemical staining was
performed on kidney sections fixed in 4% buffered formaldehyde
for 24 h fixation and embedded in paraffin. Four-micrometer
sections were incubated with monoclonal antibodies and polyclonal
antibodies directed at various markers for podocytes, PECs,
macrophages, endothelium, myofibroblasts, and matrix components
such as collagen as detailed in Table 2. As secondary antibody, we
used powervision Poly-HRP-anti Mouse/Rabbit/Rat IgG (Immuno-
logic, Klinipath, Duiven, The Netherlands). Detection was carried
out with the use of peroxidase as label and diaminobenzidine as
substrate.
Transmission electron microscopy. For electron microscopy,
we used immersion fixation. Small fragments of cortex were fixed in
2.5% glutaraldehyde, dissolved in 0.1 M sodium cacodylate buffer,
pH 7.4, overnight at 41C, and washed in the same buffer. The tissue
fragments were post-fixed in palade-buffered 2% OsO4 for 1 h,
dehydrated, and embedded in Epon812, Luft’s procedure (Merck,
Darmstadt, Germany). Ultrathin sections were contrasted with 4%
uranyl acetate for 45 min and subsequently with lead citrate for
5 min at room temperature. Sections were examined in a Jeol 1200
EX2 electron microscope (JEOL, Tokyo, Japan).
Statistical analysis
Comparisons were performed using t-test. For correlation analysis,
we used Spearman test. Logistic regression analysis was performed
to evaluate independent predictors. P-values less than 0.05 were
considered significant. All statistics were performed using SPSS
statistical software (SPSS 12.0 for Windows, SPSS Inc., Chicago, IL,
USA).
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